IL152980A0 - Use of lactobacillus casei in immunostimulatory peptides - Google Patents

Use of lactobacillus casei in immunostimulatory peptides

Info

Publication number
IL152980A0
IL152980A0 IL15298001A IL15298001A IL152980A0 IL 152980 A0 IL152980 A0 IL 152980A0 IL 15298001 A IL15298001 A IL 15298001A IL 15298001 A IL15298001 A IL 15298001A IL 152980 A0 IL152980 A0 IL 152980A0
Authority
IL
Israel
Prior art keywords
lactobacillus casei
immunostimulatory peptides
immunostimulatory
peptides
casei
Prior art date
Application number
IL15298001A
Other languages
English (en)
Original Assignee
Gervais Danone Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8850597&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL152980(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gervais Danone Sa filed Critical Gervais Danone Sa
Publication of IL152980A0 publication Critical patent/IL152980A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/125—Casei
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/245—Lactobacillus casei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL15298001A 2000-05-25 2001-04-27 Use of lactobacillus casei in immunostimulatory peptides IL152980A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0006679A FR2809312B1 (fr) 2000-05-25 2000-05-25 Utilisation de l. casei dans des compositions immunostimulantes
PCT/FR2001/001310 WO2001089541A1 (fr) 2000-05-25 2001-04-27 Utilisation de lactobacillus casei dans des peptides immunostimulantes

Publications (1)

Publication Number Publication Date
IL152980A0 true IL152980A0 (en) 2003-06-24

Family

ID=8850597

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15298001A IL152980A0 (en) 2000-05-25 2001-04-27 Use of lactobacillus casei in immunostimulatory peptides

Country Status (28)

Country Link
US (1) US7604809B2 (de)
EP (1) EP1283714B1 (de)
JP (1) JP2003534284A (de)
CN (1) CN1194707C (de)
AR (1) AR028626A1 (de)
AT (1) ATE332143T1 (de)
AU (2) AU5643501A (de)
BG (1) BG65884B1 (de)
BR (1) BR0111135A (de)
CA (1) CA2410350C (de)
CZ (1) CZ303600B6 (de)
DE (1) DE60121327T2 (de)
DK (1) DK1283714T3 (de)
EA (1) EA005081B1 (de)
ES (1) ES2267763T3 (de)
FR (1) FR2809312B1 (de)
HK (1) HK1055898A1 (de)
HR (1) HRP20020935A2 (de)
HU (1) HUP0302041A3 (de)
IL (1) IL152980A0 (de)
MA (1) MA25760A1 (de)
MX (1) MXPA02011636A (de)
NO (1) NO332369B1 (de)
PL (1) PL201801B1 (de)
PT (1) PT1283714E (de)
SK (1) SK18272002A3 (de)
WO (1) WO2001089541A1 (de)
ZA (1) ZA200209087B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6800744B1 (en) * 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
GB0009294D0 (en) 2000-04-15 2000-05-31 Sec Dep For The Home Departmen Improvements in and relating to analysis of DNA samples
US9610347B2 (en) * 2001-04-30 2017-04-04 Cortcontrol Vaccination response for immunodeficiency or high cortisol
CN1317385C (zh) * 2003-05-30 2007-05-23 上海光明乳业股份有限公司 干酪乳杆菌Bd－II菌株及其在降低血脂方面的应用
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
ATE361101T1 (de) * 2004-08-24 2007-05-15 Nutricia Nv Nahrungszusammensetzung die unverdauliche oligosaccharide enthält
ZA200705844B (en) * 2004-12-15 2008-09-25 Van Der Westhuzen Corne Floris Detoxifying and immunity-booster composition
EP1683425A1 (de) * 2005-01-21 2006-07-26 Compagnie Gervais Danone Verwendung von fermentiertem Milchprodukt enthaltend L. Casei zur Herstellung eines Zusammensetzung zur Prävention oder Behandlung Überempfindlichkeitsreaktionen vom verzögerten Typ
ES2264368B1 (es) * 2005-02-11 2007-12-01 Francisco Exposito Mesa Complemento alimenticio o dietetico compuesto por productos procedentes del lisado de microorganismos.
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
AU2006253006B8 (en) 2005-05-31 2011-09-15 Alimentary Health Ltd Feline probiotic Lactobacilli
BRPI0716997B8 (pt) 2006-09-10 2021-05-25 Glycotope Gmbh proteína ou composição de moléculas de proteína, métodos para produção e uso da mesma
FR2912657B1 (fr) * 2007-02-16 2009-04-17 Gervais Danone Sa Utilisation de lactobacillus casei pour renforcer la protection induite par la vaccination anti-grippale.
WO2009021585A1 (en) * 2007-08-13 2009-02-19 Dsm Ip Assets B.V. Probiotic bacteria for rducing the occurence of symptoms of winter infections
WO2009067000A1 (en) * 2007-11-20 2009-05-28 N.V. Nutricia Composition with synbiotics
EP2119365B1 (de) 2008-05-13 2017-08-16 Glycotope GmbH Fermentationsprozess
US8741365B2 (en) * 2008-05-13 2014-06-03 Glycotope Gmbh Fermentation process
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
EP2153837A1 (de) * 2008-08-14 2010-02-17 Compagnie Gervais Danone Zusammensetzungen mit Lactobacillus casei zur Verbesserung der Resistenz gegen verbreitete Infektionskrankheiten
FR2937252B1 (fr) * 2008-10-17 2011-05-20 Pf Medicament Association d'un extrait de sureau et d'une souche de l. paracasei.
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
WO2011083354A1 (en) * 2010-01-08 2011-07-14 Compagnie Gervais Danone Lactobacilli with anti-oxidant action
US20130121976A1 (en) * 2010-03-12 2013-05-16 Agusti Montserrat Carreras Lactic Acid Bacteria for Coeliac Disease
CN105288616B (zh) * 2010-10-15 2018-10-19 科.汉森有限公司 免疫佐剂
EP2455092A1 (de) * 2010-11-11 2012-05-23 Nestec S.A. Nicht replizierende probiotische Mikroorganismen als Schutz vor Infektionen der oberen Atemwege
CA2844543A1 (en) 2011-08-22 2013-02-28 Glycotope Gmbh Microorganisms carrying a tumor antigen
WO2014038929A1 (en) 2012-09-07 2014-03-13 N.V. Nutricia Probiotics for producing antiviral factors
CN117815404A (zh) 2018-05-18 2024-04-05 第一三共株式会社 抗-muc1抗体-药物缀合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05236872A (ja) * 1992-02-27 1993-09-17 Takanashi Nyugyo Kk 乳酸菌含有食品
JP4112021B2 (ja) * 1994-02-16 2008-07-02 明治乳業株式会社 乳酸菌を用いた免疫賦活剤
ATE173135T1 (de) * 1995-01-02 1998-11-15 Gervais Danone Co Milchsäureferment, und ihre verwendung zur herstellung von antidiarrhöeprodrukten
ES2349669T3 (es) * 1997-08-21 2011-01-10 New Zealand Dairy Board Bacterias del ácido láctico que incrementan la inmunidad.
US6699517B2 (en) * 1997-11-28 2004-03-02 Compagnie Gervais Danone Method for preparing food products by fermenting soy milk with streptococcus thermophilus
IT1298918B1 (it) * 1998-02-20 2000-02-07 Mendes Srl Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
KR100324441B1 (ko) * 1999-02-08 2002-02-27 이은선 위염, 위궤양, 십이지장궤양 예방을 위한 식품

Also Published As

Publication number Publication date
HRP20020935A2 (en) 2005-02-28
NO332369B1 (no) 2012-09-03
MA25760A1 (fr) 2003-04-01
NO20025595D0 (no) 2002-11-21
AR028626A1 (es) 2003-05-14
DK1283714T3 (da) 2006-10-30
BR0111135A (pt) 2003-04-08
WO2001089541A1 (fr) 2001-11-29
PT1283714E (pt) 2006-11-30
FR2809312A1 (fr) 2001-11-30
MXPA02011636A (es) 2003-05-14
HUP0302041A2 (hu) 2003-09-29
CA2410350A1 (fr) 2001-11-29
HK1055898A1 (en) 2004-01-30
EP1283714A1 (de) 2003-02-19
ES2267763T3 (es) 2007-03-16
CN1194707C (zh) 2005-03-30
CN1430518A (zh) 2003-07-16
CZ303600B6 (cs) 2013-01-02
BG107299A (bg) 2003-07-31
AU2001256435B2 (en) 2006-06-29
BG65884B1 (bg) 2010-04-30
EP1283714B1 (de) 2006-07-05
HUP0302041A3 (en) 2005-11-28
NO20025595L (no) 2003-01-22
DE60121327D1 (de) 2006-08-17
AU5643501A (en) 2001-12-03
PL358408A1 (en) 2004-08-09
PL201801B1 (pl) 2009-05-29
EA200201248A1 (ru) 2003-06-26
FR2809312B1 (fr) 2002-07-12
US20040029127A1 (en) 2004-02-12
CZ20024189A3 (cs) 2003-05-14
CA2410350C (fr) 2013-04-09
EA005081B1 (ru) 2004-10-28
JP2003534284A (ja) 2003-11-18
ATE332143T1 (de) 2006-07-15
DE60121327T2 (de) 2007-07-26
ZA200209087B (en) 2004-06-30
SK18272002A3 (sk) 2003-08-05
US7604809B2 (en) 2009-10-20

Similar Documents

Publication Publication Date Title
AU5643501A (en) Use of lactobacillus casei in immunostimulatory peptides
AU2001256435A1 (en) Use of lactobacillus casei in immunostimulatory compositions
HUP0301003A3 (en) Casein derived peptides and uses thereof in therapy
AU8079901A (en) Promyostatin peptides and methods of using same
IL160050A0 (en) Probiotic lactobacillus casei strains
AU7616001A (en) Probiotic recolonisation therapy
AU6723401A (en) Antimicrobial peptides and methods of use thereof
HUP0600031A3 (en) Kahalalide formulations and their use
IL153671A0 (en) Amphipathic linear peptides and formulations containing same peptides
HUP0500995A3 (en) Casein derived peptides and uses thereof in therapy
GB0026134D0 (en) Peptides and their use
EP1308509A4 (de) Neuartiges, physiologisch aktives peptid und dessen anwendungen
PL362753A1 (en) New strain of lactobacillus paracasei
EP1337543A4 (de) Streptavidin-bindende peptide und deren verwendung
SG97174A1 (en) Lactobacillus rhamnosus strain and uses thereof
EP1275659A4 (de) Physiologisch aktive peptide und anwendung derselben
IL145527A0 (en) Retro-inverso prosaposin-derived peptides and use thereof
GB0017028D0 (en) Peptides and their therapeutic use
IL151351A0 (en) Casein derived peptides and uses thereof in therapy
GB0018148D0 (en) Peptides and their use
GB0026135D0 (en) Peptides and their use
GB0026136D0 (en) Peptides and their use
AU5995701A (en) Synthetic peptides and uses therefore
GB0023059D0 (en) Virulence gene and protein and their use
GB0002556D0 (en) Virulence gene and protein and their use